Financial Year |
March 31 2023 |
Monetary Funds |
3,649,596,018.73 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
306,443,789.99 |
Accounts Receivable |
1,326,619,862.48 |
Advances to Suppliers |
280,149,382.05 |
Other Receivables |
111,179,350.93 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
26,158,508.39 |
Dividend Receivable |
-- |
Inventories |
1,342,112,511.35 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
151,861,134.62 |
Total Current Assets |
7,172,568,726.85 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
4,635,462.74 |
Investment Properties |
-- |
Fixed Assetes |
2,926,781,253.67 |
Under-construction Projects |
87,389,790.48 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
123,794,871.15 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
4,924,317.80 |
Deferred Income Tax Assets |
141,424,964.57 |
Other Non-Current Assets |
11,538,105.82 |
Sub-Total of Non-Current Assets |
3,485,253,700.53 |
Total Assets |
10,657,822,427.38 |
Short-Term Loans |
409,615,548.30 |
Trading Financial liabilities |
17,742,281.91 |
Notes Payable |
2,505,132,462.49 |
Accounts Payable |
2,083,683,268.39 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
37,563,710.26 |
Taxes Payable |
11,349,771.95 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
125,107,192.70 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
229,220,644.82 |
Other Current Liabilities |
317,106,699.80 |
Sub-Total of Current Liabilities |
6,328,534,431.56 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
668,503,804.52 |
Special Payable |
-- |
Estimatied Liabilities |
559,538,459.19 |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,305,071,640.38 |
Total Liabilities |
7,633,606,071.94 |
Paid-In Capital(Or Share Stock) |
1,192,859,268.00 |
Capital Surplus |
1,548,337,486.30 |
Surplus Reserve |
48,150,769.04 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-184,604,232.03 |
Minority Stockholder's Interest |
419,981,754.76 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,604,234,600.68 |
Owner's Equity(Stockholder's Equity) |
3,024,216,355.44 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
10,657,822,427.38 |